Tue.May 20, 2025

article thumbnail

Opinion: I study diet and chronic illness. Here’s the uncomfortable truth about seed oils

STAT

For decades, mainstream nutrition guidelines have recommended that Americans replace animal fats like butter or lard with polyunsaturated fats, especially seed oils such as soybean, corn, and sunflower oils. These oils are rich in omega-6 fatty acids and now make up a significant portion of the fat consumed in the standard American diet. But recently, the conversation has shifted.

119
119
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

With most eyes on Medicaid cuts in Congress, keep a close eye on ACA enrollment over the next six months, warn health policy experts.

99
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Maryland governor signs law to expand powers of the state’s prescription drug affordability board

STAT

In a notable development, Maryland Gov. Wes Moore signed a bill that will allow a state board to extend its mandate for lowering prescription drug costs to all residents, not just those employed by government agencies. The move was hailed by consumer advocates who hope the Prescription Drug Affordability Board, which is designed to function much like a state utility commission, will usher in era of lower medicine prices for everyone who lives in Maryland.

107
107
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

In a briefing held by the Catholic Health Association, hospital leaders referred to the moral imperative they and Congress share to preserve the countrys safety net.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

New FDA framework on Covid vaccines leaves pediatricians confused and concerned

STAT

A new framework for Covid-19 vaccines announced by Food and Drug Administration leaders Tuesday suggests the agency will no longer approve new Covid vaccines for healthy individuals under 65, including babies, without data from new randomized clinical trials showing their benefit.  The plan — described in a commentary in the New England Journal of Medicine, followed by a live stream on YouTube — created confusion among physicians about what it means for young children.

Vaccines 145
article thumbnail

Triple-Combination Therapy Met Primary End Point in Phase 3 Trials, Providing Treatment for Individuals With Asthma

Pharmacy Times

A new triple-combination therapy shows promise in improving asthma management, offering hope for millions with uncontrolled symptoms.

123
123

More Trending

article thumbnail

Anti-Diabetic Drug Could Offer New Treatment for Prostate Cancer

Pharmacy Times

Research reveals pioglitazone, a diabetes drug, may slow prostate cancer progression, offering new hope for patients with both conditions.

89
article thumbnail

STAT+: Mental health apps can boost outcomes and lower costs, study finds

STAT

Developers of digital mental health treatments now have fresh economic data to help make the case for broader coverage of their apps. Companies selling Food and Drug Administration-cleared apps for the treatment of psychiatric and other conditions have long struggled with adoption by patients, providers, and payers for many reasons. Clinical evidence supporting these prescription digital therapeutics has gradually improved , but policymakers and insurers have been hesitant to open the path to re

Insurance 103
article thumbnail

O'Shaughnessy says UK clinical trials sector is on the mend

pharmaphorum

After losing ground in commercial clinical trials in recent years, the UK has now turned a corner and is once again taking a "global lead"

59
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

A cyberattack is causing a system-wide technology outage at Kettering Health and its network of more than a dozen medical centers in Ohio.

82
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Blunt Rochester presses RFK Jr. on CDC acting director

STAT

Sen. Lisa Blunt Rochester has written a stinging letter to Health Secretary Robert F. Kennedy Jr. demanding that he clarify whether the Centers for Disease Control and Prevention has an acting director. In her three-page missive, Blunt Rochester suggested that Matthew Buzzelli, the person Kennedy said was the CDC’s acting director, cannot hold the role because he isn’t qualified under the federal Vacancies Act.

81
article thumbnail

HHS sets “most favoured nation” pricing targets for drug makers

Pharmaceutical Technology

Drug manufacturers will now have to commit to the new pricing model to avoid regulatory action in the US.

52
article thumbnail

Real-world evidence in CNS research: Past, present, future

pharmaphorum

Patient-centric, large-scale real-world studies, which use data collected outside the system of controlled clinical trials, can and have already been delivered successfully. The tools, systems, and processes are available today, and modern technology has made it much easier to successfully run a real-world CNS study.

52
article thumbnail

ATS 2025: ETI-linked mucus clearance tied to lung function gains in paediatric CF

Pharmaceutical Technology

Data presented at ATS 2025 showed that lung improvement in paediatric cystic fibrosis (CF) patients receiving ETI therapy is driven by regional mucus plug clearance.

52
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Duck Creek Technologies appoints Tyler Jones as chief marketing officer

Pharmafile

Duck Creek Technologies has appointed Tyler Jones as its new chief marketing officer (CMO). He will lead the companys global marketing strategy, supporting its position as a provider of property and casualty (P&C) insurance software. Jones brings more than two decades of experience at the intersection of insurance, technology and customer experience.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

An independent report found that self-guided content and prescription digital therapeutics saved money while blended therapy models raised costs.

79
article thumbnail

ATS 2025: Sanofi and Regeneron to launch new AIM4 trial for personalised asthma care

Pharmaceutical Technology

At ATS 2025, Sanofi and Regeneron announced the launch of a new Phase IIIb/IV clinical trial, AIM4, for asthma care.

52
article thumbnail

Glofit-GemOx in R/R DLBCL: FDA Advisory Committee Reviews STARGLO Phase 3 Results for Transplant-Ineligible Patients

Pharmacy Times

Glofitamab combined with GemOx shows promising survival benefits for patients with relapsed DLBCL, offering a new treatment option for those ineligible for transplants.

FDA 65
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Pfizer signs global licensing deal with 3SBio for bispecific antibody

Pharmaceutical Technology

Pfizer has signed a worldwide licensing agreement, excluding China, with biopharmaceutical company 3SBio for SSGJ-707.

52
article thumbnail

Understanding the Toxicity Profiles of Fat-Soluble Vitamins: Insights Into Vitamins A, D, E, and K

Pharmacy Times

Health care professionals play a vital role in preventing overdose and ensuring safe use.

65
article thumbnail

Next‑Gen Pharma: AI, ML & Digital Twins Converge at AUTOMA+ 2025

Pharmaceutical Technology

The 5th Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) will gather industry leaders in Vsendorf, Austria on 24-25 November for indepth case studies, practical workshops and highimpact networking designed to accelerate pharmas digital journey.

86
article thumbnail

STAT+: Pharmalittle: We’re reading about FDA eyeing PDUFA changes, compounded weight loss drugs, and more

STAT

Top of the morning to you, and a fine one it is. Clear, blue skies and comfortable breezes are enveloping the Pharmalot campus, where the short person is sleeping in and the official mascots are threatening local cats to keep their distance. As for us, we are engaged in the usual rituals — firing up the coffee kettle in order to brew a cup of stimulation (the choice today is pecan bourbon) and foraging for items of interest.

article thumbnail

Countries formally adopt WHO’s Pandemic Agreement for future pandemics

Pharmaceutical Technology

The agreement will see international initiatives to fight the next pandemic, but funding remains the weak link.

59
article thumbnail

Declines in Pediatric Pneumococcal Complicated Pneumonia Evident Following Introduction of Higher Valent Vaccines

Pharmacy Times

A systematic review reveals declining pediatric pneumococcal complicated pneumonia rates following the introduction of pneumococcal conjugate vaccine 13.

article thumbnail

ATS 2025: Anti–IL-5 therapy cuts exacerbations in coexisting COPD and asthma patients

Pharmaceutical Technology

An ATS 2025 session presented data showing that antiIL-5 biologics significantly cut exacerbations in coexisting asthma and COPD patients.

52
article thumbnail

Regeneron makes another deal — This one about AI

STAT

Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Good morning health tech readers!

62
article thumbnail

Mentorship, Leadership, and Professional Growth in Oncology Pharmacy

Pharmacy Times

Don Moore, PharmD, BCPS, BCOP, DPLA, FCCP, FASHP received a leadership award at the 2025 HOPA Annual Meeting.

65
article thumbnail

New real-world data guidance could accelerate drug approvals

European Pharmaceutical Review

On International Clinical Trials Day 2025, the Medicines and Healthcare products Regulatory Agency (MHRA) has declared there has been major progress in the delivery of regulatory framework to make UK clinical trials more efficient and flexible. Last month, we began implementing the most significant update to UK clinical trials regulation in over two decades.

52
article thumbnail

Pharmaceutical Technology Excellence Awards 2025: Novotech 

Pharmaceutical Technology

Novotech is a winner in the Diversity, Research and Development, and Marketing categories in the 2025 Pharmaceutical technology Excellence Awards.

59
article thumbnail

UK's long-term R&D investment policy welcomed

pharmaphorum

The decision by the UK to set new 10-year budgets for public R&D funding has received a positive response from academia and the pharma industry

55
article thumbnail

ATS 2025: Real-world data supports Trikafta as gold standard in long-term CF care

Pharmaceutical Technology

The published long-term data suggests that the treatment could maintain its dominant position in the CF market.

52
article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Employers are continuing to invest in their wellbeing programs, but they will be raising the bar for what's expected from their vendors.

52
article thumbnail

Skye and Arecor to develop higher formulation of CB1 inhibitor

Pharmaceutical Technology

Skye has entered a partnership with Arecor aimed at developing a higher formulation of the formers obesity candidate, nimacimab.

52